ABOUT THIS EVENT

Moonlake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, visits the Nasdaq MarketSite in Times Square to celebrate its admission to trading on the Nasdaq stock market.

In honor of the occasion, Jorge Santos da Silva, co-founder and CEO, rings the Closing Bell.